Drug intelligence / Profile preview

BioCell Collagen

Development stage: Unknown
Lead developer: BioCell Technology
Administration: Oral

Overview

BioCell Collagen is a patented, naturally occurring matrix of hydrolyzed collagen type II, chondroitin sulfate, and hyaluronic acid. It is derived from chicken sternal cartilage using a patented hydrolysis process that reduces the molecular weight of the components for improved bioavailability and absorption. As a nutraceutical, it is primarily used to support joint health by providing structural components for cartilage repair and lubrication, and to support skin health by improving hydration and reducing the appearance of wrinkles. It is marketed by Faran Shimi in Iran as a supplement for joint and skin maintenance.

Brand names: BioCell Collagen
Other names: Hydrolyzed Collagen Type IIChicken Sternal Cartilage Extract

Targets

HYAL (Hyaluronidase family (HYAL))

Beyond the preview

Go deeper on BioCell Collagen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioCell Collagen.

Explore the full profile